150 likes | 288 Views
8 th Annual Track 1.0 ART Meeting. FHI’s Global ART Program: Today's snapshot and tomorrow's vision 10 August 2010. Kwasi Torpey, MD, PhD, MPH Regional Senior Technical Advisor, FHI. Part 1: Today’s Snapshot Overview of FHI’s Global ART Program. Provision of ART in 14 countries
E N D
8th Annual Track 1.0 ART Meeting FHI’s Global ART Program:Today's snapshot and tomorrow's vision10 August 2010 Kwasi Torpey, MD, PhD, MPH Regional Senior Technical Advisor, FHI
Part 1: Today’s SnapshotOverview of FHI’s Global ART Program Provision of ART in 14 countries across Asia, Africa and the Caribbean 322,586 patientscurrently on ART as of March 2010; of those: 102,164 (31.7%) are in Zambia 101,700 (31.5%) are in Nigeria 23,245 (7.2%) are less than 15 yrs. old 30,091 patients were newly enrolled on ART from Jan 2010 – March 2010 2,143 (7.1%) are less than 15 yrs. old
Early Infant Diagnosis (EID): Dried Blood Spot DNA-PCR Currently being implemented in 6 African countries: Zambia, Kenya, Nigeria, Mozambique, Tanzania & Rwanda Over 45,000children tested through EID 27,274 in Zambia alone Systems for early delivery of results and integration into under 5 clinics sms printers Web2sms for results pick up
Early Infant Diagnosis (EID): Dried Blood Spot DNA-PCR (2) Linking DBS results to determine effectiveness of PMTCT intervention Assessing the role of non drug factors eg. Disclosure, infant feeding, home vs facility to optimize effectiveness and efficiency in the light of limited resources
Part 2: Tomorrow’s VisionThe Future of ART programming Health Systems Strengthening platform Integration of HIV services beyond Sexual, Reproductive Health & TB. One target community, many diseases! Long-term tracking of ART patients Sustainability
Overview of FHI’s TB/HIV Services Screening for TB and/or provision of TB treatment for HIV+ patients in 15 countries Integration of TB-HIV services As of March 2010: 149,808 HIV+ patients were screened for TB in HIV setting 5,699 HIV+ patients in HIV care/treatment started TB treatment
FHI Kenya’s CVD/HIV Integration Pilot Assess CVD risk factors among: HIV Counseling & Testing (CT) clients HIV+ patients in care HIV+ patients on ART Provide behavioral and biomedical interventions (on site and/or through referral) Document and disseminate lessons learned
Rationale for integration CVD complications in HIV patients Burden of CVD and HIV among developing countries; In Kenya: HIV prevalence is 7.1%, with 1.5 Million PLWHA, and 390,000 on HAART NCD contributes to 50% morbidity and 32% mortality (Kenya MOH, 2007) Opportunity to combine lessons learned in CVD &HIV Improve efficiency of health care delivery
Risk of high blood pressure according to HIV status (among CT clients) P-value 0.003
Other findings Elevated blood sugar levels in 2nd line patients Increased lipids in second line patients High blood pressure related to duration of treatment
Strategies for tracking ART Patients Adherence support workers Home visits and patient tracking SMS reminders Web2sms for adherence and loss to follow up Consent forms HMIS Smartcare - Zambia 93,233 current ART patients (6,844 >15 yrs. – 7.3%) Lafiya Management Information System (LAMIS) - Nigeria
Lafiya Management Information System (LAMIS) - Nigeria 60,361 patients being tracked 14 facilities Data included: Patient history ART status and drug regimen TB and DOTS status Clinical stage Lab tests & results Facility and lab setup Specimen storage Drug Inventory
Attaining operational sustainability Technical Sustainability Operational Sustainability OVERALL SUSTAINABILITY Programmatic Sustainability Social Sustainability Financial Sustainability
Challenges for Sustainability Limited pre-service & in-service exposure to QI concepts Absence of strong QI system within MoH Use of financial incentives to drive QI & graduation activities High HCW turnover rate Financial sustainability